I’m with CDiddy on this. I think we hit a homerun at day 28. I think day 42 would be even better for a grandslam. All studies I have seen have an avg of 30% mortality at day 28 and most had more exclusions and left out the most sick unlike cd-12 trial. I think we have excellent shot at full approval and close to guarantee at EUA.